Search results - ORA - Oxford University Research Archive

1

Conference item

ARCII: Nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy (CRT) in locally-advanced pancreatic cancer (LAPC)–mechanism and clinical outcomes

Wilson, J, Dutton, S, Hackett, S, et al.
2017-01-31

2

Conference item

Dosimetric parameters predict toxicity in chemoradiotherapy with nelfinavir for pancreatic cancer

Holyoake, D, Wilson, J, Partridge, M, et al.
2016-08-21

3

Journal article

Correlation of 18F-fluorodeoxyglucose positron emission tomography parameters with patterns of disease progression in locally advanced pancreatic cancer after definitive chemoradiotherapy

Wilson, J, Mukherjee, S, Brunner, T, et al.
2017-02-01

4

Journal article

Targeting ATR in DNA damage response and cancer therapeutics.

Fokas, E, Prevo, R, Hammond, E, et al.
2014-02-01

5

Journal article

Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinoma.

Mantoni, T, Schendel, R, Rödel, F, et al.
2008-11-01

6

Journal article

The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy.

Prevo, R, Fokas, E, Reaper, P, et al.
2012-09-01

7

Journal article

Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.

Fokas, E, Prevo, R, Pollard, J, et al.
2012-01-01

8

Journal article

Cancer stem cells as a predictive factor in radiotherapy.

Brunner, T, Kunz-Schughart, L, Grosse-Gehling, P, et al.
2012-04-01

9

Journal article

Quality of training in radiation oncology in Germany. Results of a 2006 survey.

Semrau, R, Hansemann, K, Adam, M, et al.
2008-05-01

10

Conference item

A phase I trial of the farnesyltransferase and geranylgeranyltransferase-I inhibitor L-778,123 (L-778) and radiotherapy for locally advanced pancreatic cancer.

Martin, N, Brunner, T, Bernhard, E, et al.
2004-07-15

11

Conference item

Radioresistance of cancer stem cells

Brunner, T, Al-Assar, O, Muschel, R, et al.
2009-09-01

12

Journal article

Comparison of four target volume definitions for pancreatic cancer. Guidelines for treatment of the lymphatics and the primary tumor.

Fokas, E, Eccles, C, Patel, N, et al.
2013-05-01

13

Journal article

Targeting ATR in DNA damage response and cancer therapeutics

Fokas, E, Prevo, R, Hammond, E, et al.
2014-01-01

14

Journal article

Radiation response of cancer stem-like cells from established human cell lines after sorting for surface markers.

Al-Assar, O, Muschel, R, Mantoni, T, et al.
2009-11-01

15

Journal article

Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinoma

Mantoni, T, Schendel, R, Rödel, F, et al.
2008-11-01

16

Journal article

Farnesyltransferase inhibitors as radiation sensitizers.

Brunner, T, Gupta, A, Shi, Y, et al.
2003-07-01

17

Conference item

PREOPERATIVE CHEMORADIATION FOR RESECTABLE ADENOCARCINOMA OF THE PANCREAS (ISRCTN 78805636): PATTERN OF RECURRENCE.

Golcher, H, Witzigmann, H, Marti, L, et al.
2012-06-01

18

Conference item

A phase I-trial of the HIV protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer

Brunner, T, Geiger, M, Grabenbauer, G, et al.
2008-05-01

19

Conference item

Predicting Respiratory Motion for Patients Undergoing Pancreatic Chemoradiation in the Absence of Volumetric Motion Imaging

Eccles, C, Scott-Brown, M, McKenna, W, et al.
2010-01-01

20

Journal article

Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost.

Brunner, T, Rupp, A, Melzner, W, et al.
2008-01-01

21

Conference item

A comprehensive comparison of IMAT and 3D-CRT plan quality for gastrointestinal organ sparing and NTCP using the Eclipse Radiobiological modelling software

Warren, S, Fokas, E, Partridge, M, et al.
2013-05-01

22

Conference item

A comprehensive dosimetric comparison of four target volume definitions for pancreatic cancer and their influence on lymphatics and organs at risk

Fokas, E, Eccles, C, Patel, N, et al.
2013-05-01

23

Journal article

Combining molecular targeted therapeutics (MTT) and radiotherapy: MTT and MTD.

Brunner, T, McKenna, G
2011-09-01

24

Journal article

Pancreatic cancer cell radiation survival and prenyltransferase inhibition: the role of K-Ras.

Brunner, T, Cengel, K, Hahn, S, et al.
2005-09-01

25

Conference item

The Radiation Response of Cancer Stem Cell-like Subpopulations from Established Human Cell Lines

Brunner, T, Al-Assar, O, Muschel, R, et al.
2009-01-01

26

Journal article

The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cells

Al-Assar, O, Bittner, M, Lunardi, S, et al.
2016-05-28

27

Thesis

Tumour-stroma interaction in pancreatic cancer

Lunardi, S
2013

28

Journal article

Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients.

Brunner, T, Sauer, R, Fietkau, R
2011-01-01

29

Conference item

A Comparison of contrast-reinforced lever Computed tomography (CECT) with FDG-PET-based Target volume definition in locally advanced Pancreatic Cancer (LAPC) for conventional and adaptive Radiochemotherapy (RCT)

Eccles, C, Vallis, K, Mckenna, W, et al.
2011-06-01

30

Conference item

ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation

Fokas, E, Prevo, R, Pollard, JR, et al.
2013-05-01

31

Journal article

Gemcitabine-based chemoradiotherapy in locally advanced pancreas carcinoma - A meta-analysis

Brunner, T
2012-04-01

32

Journal article

Knockdown of the integral membrane protein caveolin-1 sensitizes human pancreatic carcinoma cells to ionizing radiation

Cordes, N, Frick, S, Hehlgans, S, et al.
2008-02-01

33

Journal article

Progress towards the use of HIV protease inhibitors in cancer therapy

Bernhard, E, Brunner, T
2008-05-01

34

Conference item

The novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy

Fokas, E, Prevo, R, Reaper, P, et al.
2012-06-01

35

Journal article

Radiotherapy and chemotherapy as therapeutic strategies in extrahepatic biliary duct carcinoma.

Brunner, T, Eccles, C
2010-12-01

36

Journal article

Oncogenic K-Ras signals through epidermal growth factor receptor and wild-type H-Ras to promote radiation survival in pancreatic and colorectal carcinoma cells.

Cengel, K, Voong, K, Chandrasekaran, S, et al.
2007-04-01

37

Conference item

The Interaction of pancreatic Cancer and Stellate Cells as a Mediator of Radiation Resistance in ductal Pancreatic Adenocarcinoma

Mantoni, T, Lunardi, S, Mckenna, W, et al.
2011-06-01

38

Journal article

Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy.

Golcher, H, Brunner, T, Grabenbauer, G, et al.
2008-07-01

39

Journal article

Radiotherapy research priorities for the UK.

Maughan, T, Illidge, T, Hoskin, P, et al.
2010-10-01

40

Journal article

Progress towards the use of HIV protease inhibitors in cancer therapy.

Bernhard, E, Brunner, T
2008-05-01

41

Journal article

Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Eckel, F, Brunner, T, Jelic, S
2010-05-01

42

Journal article

Farnesyltransferase inhibitors: an overview of the results of preclinical and clinical investigations.

Brunner, T, Hahn, S, Gupta, A, et al.
2003-09-01

43

Journal article

Comparing dose-volume histogram and radiobiological endpoints for ranking intensity-modulated arc therapy and 3D-radiotherapy treatment plans for locally-advanced pancreatic cancer.

Warren, S, Partridge, M, Fokas, E, et al.
2013-10-01

44

Journal article

Comparison of Locally Advanced Pancreatic Cancer Target Definition Methods on 18FDG-PET images for Radiotherapy Treatment Planning

Eccles, C, Vallis, K, Brunner, T, et al.
2011-01-01

45

Journal article

Downstaging of pancreatic carcinoma after neoadjuvant chemoradiation.

Tinkl, D, Grabenbauer, G, Golcher, H, et al.
2009-09-01

46

Journal article

Radiotherapy in pancreatic cancer.

Klautke, G, Brunner, T
2008-11-01

47

Conference item

A Comparison of 4 Target Volume Definitions for Pancreatic Cancer: Two Concepts Including the Lymphatics (RTOG and ARO) and 2 Concepts Only Treating the Primary Tumor (Michigan and UK-SCALOP)

Brunner, T, Fokas, E, Eccles, C, et al.
2012-11-01

48

Journal article

Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis | Gemcitabin-basierte Strahlenchemotherapie beim lokal fortgeschrittenen Pankreaskarzinom - eine Metaanalyse

Brunner, T
2012-01-01

49

Conference item

Predicting Respiratory Motion for Patients Undergoing Pancreatic Chemoradiation in the Absence of Volumetric Motion Imaging

Eccles, C, Scott-Brown, M, Mckenna, W, et al.
2010-01-01

50

Journal article

[The role of radiochemotherapy in multimodal therapy of pancreatic cancer].

Brunner, T, Sauer, R
2007-04-01

EXPLORE THE UNIVERSITY OF OXFORD'S WORLD-CLASS RESEARCH